Menu
Gilead Sciences (GILD) $45.19
The Company:
Founded in 1987 in Foster City, California, Gilead Sciences is a research-based biotech company that focuses on HIV/AIDS, liver disease and cardiovascular/metabolic and respiratory conditions. While the company has products to treat cardiovascular and respiratory diseases, it derives a bulk of its revenue and profits from antiviral drugs used to treat HIV and Hepatitis B. Gilead has two billion dollar antiviral drugs called Altripla and Truvada, which are both used in the treatment of HIV. Truvada is a combination of two different drugs and Altripla is a combination of Truvada and yet another drug.